PEMF and Blood Circulation: What Does the Research Show?

PEMF has been studied for possible effects on blood flow, microcirculation, vascular function, and tissue oxygen use. The research does show measurable circulatory changes in some human studies, particularly when PEMF is applied locally to tissue with impaired circulation. But the evidence is not consistent enough to support the broad claim that PEMF simply “improves circulation” in every person or with every device.

That distinction matters because circulation is not one single outcome. Researchers may measure capillary blood velocity, skin perfusion, arterial dilation, blood pressure, oxygen extraction, or wound healing. A positive result in one of those measures does not automatically establish improvement in the others.

The most accurate reading of the current evidence is that certain PEMF protocols have produced measurable local vascular effects in specific clinical settings, while results in healthy populations and for broader systemic circulation remain mixed or uncertain.

For a wider explanation of how study design, device parameters, and transferability affect PEMF evidence, see our guide to PEMF research and evidence.

What Does “Improved Circulation” Mean in PEMF Research?

“Circulation” is often used as a broad consumer term, but researchers study several different physiological processes.

Local microcirculation refers to blood movement through very small vessels and capillary beds close to the tissue being measured. Researchers commonly assess it with methods such as laser Doppler flowmetry.

Vascular reactivity describes how well blood vessels dilate in response to changes in blood flow. Flow-mediated dilation, or FMD, is one method used to assess endothelial function.

Tissue oxygenation and oxygen extraction describe how oxygen is delivered to and used by working tissue. These measurements can change even when researchers are not directly measuring total blood-flow volume.

Systemic hemodynamics include measures such as systolic blood pressure, diastolic blood pressure, mean arterial pressure, and sometimes circulating nitric oxide.

These endpoints are related, but they are not interchangeable. A study showing greater capillary blood velocity near a diabetic foot ulcer does not prove that PEMF increases whole-body circulation. Likewise, a change in muscle oxygen extraction during exercise does not necessarily mean that resting blood flow increased.

What Have Human Studies Found?

Local microcirculation in diabetic foot ulcers

One of the clearest direct measurements comes from a 2015 pilot study by Kwan and colleagues involving 13 people with chronic diabetic foot ulcers.

Participants received either active PEMF or sham treatment. The active intervention used a localized disc applicator at 12 Hz and 12 Gauss for 60 minutes per session, with 14 sessions delivered over three weeks.

Researchers measured cutaneous microcirculation using laser Doppler flowmetry. In the active PEMF group, cumulative capillary blood velocity increased by 28 percent and capillary diameter increased by 14 percent. The control group showed decreases in both measures.

Those results are notable because the investigators measured local vascular behavior directly rather than inferring circulation from symptoms.

However, the study was extremely small. It involved only 13 participants, all of whom had chronic diabetic foot ulcers and substantially impaired local circulation. The results therefore cannot be assumed to represent the response of healthy tissue or the response to a different PEMF device.

The delivery method also matters. This was a localized clinical applicator placed directly over the affected region, not a full-body consumer mat.

A larger 2016 randomized trial examined 22 people with diabetes and 21 healthy controls using 0.5 mT, 12 Hz PEMF for 30 minutes. PEMF produced a greater change in the velocity of the smallest observable vein than sham in both diabetic and healthy participants, but there were no significant between-group differences in vein diameter or the two laser-Doppler skin-perfusion measures. This is a useful example of why one positive vascular endpoint should not be treated as proof of a broad circulation effect.

Healthy volunteers did not show the same local advantage

A useful counterpoint comes from a 2020 study by Biermann and colleagues involving 15 healthy volunteers.

The researchers applied a BEMER electromagnetic system to one leg while the other leg served as an untreated internal control. Cutaneous blood flow, mixed venous oxygen saturation, and relative venous hemoglobin were monitored during repeated sessions.

Blood-flow-related measurements increased during the experiment in both legs. But when the treated and untreated legs were compared directly, the PEMF-treated side did not show a significant advantage. In fact, flow was statistically higher in the untreated control leg in the direct comparison.

This does not prove that PEMF can never affect circulation in healthy people. It does show why results from patients with severely compromised circulation should not automatically be generalized to healthy users.

The vascular system is tightly regulated. Tissue that begins with normal blood flow may not respond in the same way as ischemic or poorly perfused tissue.

What About Blood Pressure and Endothelial Function?

Some research has looked beyond superficial capillary flow and examined larger-scale vascular function.

A controlled 2020 study described in the research record involved 30 people with hypertension, 26 of whom completed the protocol. Participants in the PEMF group underwent treatment over 12 weeks.

Researchers measured flow-mediated dilation, blood pressure, and circulating nitric oxide. The PEMF group showed statistically significant improvements in flow-mediated dilation and reductions in systolic, diastolic, and mean arterial blood pressure compared with controls. Plasma nitric oxide, however, did not significantly change.

That finding is interesting because flow-mediated dilation is a recognized measure of endothelial function.

There is also an important limitation: The study used a portable Biomobie device operating at 30 ± 3 Hz, with reported axis-specific magnetic-field strengths of approximately 0.06 to 0.22 mT. Participants applied it to the hands and feet for three 16-minute sessions per day over 12 weeks. The paper does not clearly report waveform or complete field-at-tissue dosimetry, so direct comparison with another PEMF device remains limited. Without those details, it becomes difficult to determine what type of electromagnetic exposure produced the result or whether another device could reasonably be expected to reproduce it.

A 2019 double-blind randomized study involving 44 people with metabolic syndrome produced similarly nuanced findings. Plasma nitric oxide increased significantly in the PEMF group after 12 weeks, while the sham group did not show the same increase. Resting blood pressure did not significantly differ between groups across the full study population, although exercise blood pressure and a hypertensive subgroup showed more favorable changes.

The study did report a Bioboosti/Biomobie portable device, a 30 ± 3 Hz operating frequency, axis-specific field strengths, hand-and-foot placement, and 48 minutes of exposure per day. However, waveform and complete field-at-target details were not reported, so the protocol still should not be generalized to all PEMF devices.

Muscle Oxygenation Is Not the Same as Blood Flow

Another line of research examines how muscle handles oxygen during physical activity.

In a 2021 randomized crossover study, 18 male cyclists completed exercise conditions with PEMF turned on and off. Near-infrared spectroscopy was used to measure oxygen-related changes in working muscle.

The researchers reported faster deoxyhemoglobin kinetics and higher deoxyhemoglobin values during PEMF exposure, which they interpreted as enhanced local oxygen extraction.

That result is relevant to vascular and metabolic research, but it should not be simplified into “PEMF increased circulation.”

Near-infrared spectroscopy in this context reflects how oxygen is extracted and used within exercising muscle. It does not directly measure the absolute volume of blood passing through that tissue.

This distinction is important because different physiological endpoints answer different questions.

Why Do Some Studies Show Positive Results While Others Do Not?

PEMF is not a standardized exposure.

Clinical studies have used very different frequencies, field strengths, applicator geometries, pulse characteristics, session lengths, treatment schedules, and target tissues. The populations also vary dramatically.

A study of a localized 12 Hz, 12 Gauss field applied to a diabetic foot ulcer is not physiologically equivalent to a study of healthy volunteers using another device with another signal pattern.

Several variables can influence the result:

• baseline vascular health
• frequency
• magnetic-field intensity
• waveform and pulse characteristics
• applicator size and geometry
• distance between the applicator and target tissue
• session duration
• number of exposures
• body area treated
• measurement method
• whether the outcome is local or systemic

This heterogeneity is one of the largest limitations in the PEMF circulation literature. A positive result tells us something about the protocol that was actually studied. It does not automatically establish a universal PEMF effect.

Is Nitric Oxide the Mechanism?

One proposed explanation for vascular effects involves nitric oxide.

Preclinical research has investigated a pathway in which electromagnetic stimulation may influence calcium and calmodulin signaling inside endothelial cells. That signaling can activate endothelial nitric oxide synthase, which contributes to nitric oxide production.

Nitric oxide helps vascular smooth muscle relax, allowing blood vessels to dilate.

Animal and laboratory research cited in the evidence review has reported vascular changes consistent with this pathway. In some experiments, blocking nitric oxide synthase prevented the observed vasodilation, strengthening the argument that nitric oxide played a role under those experimental conditions.

That is biologically interesting, but it should remain in the correct evidence lane.

It does not establish that every PEMF device produces a clinically meaningful nitric oxide response in humans. Human studies have produced inconsistent nitric oxide findings, and many clinical trials do not report enough signal parameters to determine whether the same mechanism should be expected.

So the nitric oxide pathway is best understood as a plausible mechanism supported substantially by preclinical evidence, not as proof that consumer PEMF systems universally increase blood flow.

Where Is the Evidence Most Convincing?

The clearest positive findings in the supplied research appear in localized clinical applications involving tissue with impaired circulation.

Diabetic foot-ulcer research is particularly relevant because researchers have directly measured capillary blood velocity, vessel diameter, skin perfusion, and related vascular endpoints.

Studies involving venous ulcers and other compromised tissues have also reported favorable clinical outcomes, although some of those trials used wound healing rather than direct hemodynamic measurement. Wound improvement may be clinically important, but it is not itself a direct measurement of circulation.

The pattern therefore looks more specific than the phrase “PEMF improves circulation” suggests.

The evidence is better described as showing that some targeted electromagnetic protocols have influenced local perfusion or vascular function under particular clinical conditions.

Where Is the Evidence Still Uncertain?

Several important questions remain unresolved.

First, evidence in healthy populations is limited. The healthy-volunteer study described above did not demonstrate a local blood-flow advantage for PEMF over the untreated control limb.

Second, many studies are small. Some of the most striking microcirculation findings come from pilot trials with fewer than 20 participants.

Third, device reporting is inconsistent. Several studies do not provide complete information about frequency, intensity, waveform, or applicator geometry.

Fourth, different studies measure different outcomes. Blood pressure, skin perfusion, capillary velocity, vessel diameter, oxygen extraction, and wound healing cannot all be treated as equivalent evidence for one broad circulation claim.

Finally, relatively little objective hemodynamic research has directly tested full-body consumer PEMF mats using the same circulation endpoints used in localized clinical trials.

Can These Findings Be Applied to Consumer PEMF Mats?

Only cautiously.

The studies with the clearest positive circulation findings often used localized clinical applicators positioned directly over or close to the tissue being studied. Some used substantially different frequencies, field intensities, or even pulsed radio-frequency systems.

Consumer PEMF mats use their own coil layouts, field strengths, frequencies, waveforms, and exposure patterns.

That means a clinical finding cannot be transferred simply because both products are described as PEMF.

A more defensible comparison asks whether the consumer device resembles the studied intervention in the characteristics that could affect the result, including:

• applicator geometry
• field intensity at the target tissue
• frequency
• waveform
• pulse characteristics
• exposure duration
• treatment area
• population
• endpoint being measured

Without reasonable alignment across those variables, transferability becomes uncertain.

This is particularly important for circulation research because many positive studies involve diseased or ischemic tissue, whereas consumer wellness products are often used by people who are not being treated for vascular disease.

The research can therefore help us understand what electromagnetic stimulation has done under specific experimental conditions, but it does not by itself establish that a consumer PEMF mat will reproduce the same circulatory outcome.

What Does the Current Evidence Support?

The human research supports a more specific conclusion than either “PEMF works for circulation” or “PEMF has no effect on circulation.”

Some controlled studies have found measurable improvements in localized microcirculation, vascular reactivity, or related hemodynamic measures, particularly in people with impaired vascular function.

Other studies, including research in healthy volunteers, have not shown a meaningful advantage over the comparison condition.

The results also depend heavily on the population studied, the PEMF system used, the signal parameters, the body area treated, and the outcome researchers chose to measure.

So the most defensible conclusion is:

PEMF has shown potentially meaningful vascular effects in certain clinical settings, particularly localized applications involving compromised circulation, but current evidence does not establish that PEMF universally increases circulation or that the same findings automatically apply to consumer PEMF mats.

That is why individual PEMF studies are most useful when read in the context of their exact protocol rather than treated as proof of a single category-wide effect.

Selected Research Discussed

Kwan RL-C, Wong W-C, Yip S-L, Chan K-L, Zheng Y-P, Cheing GL-Y. Pulsed electromagnetic field therapy promotes healing and microcirculation of chronic diabetic foot ulcers: a pilot study. Advances in Skin & Wound Care. 2015. DOI: 10.1097/01.ASW.0000462012.58911.53.

Biermann N, Sommerauer L, Diesch S, Taeger CD, Kehrer A, et al. The influence of pulsed electromagnetic field therapy (PEMFT) on cutaneous blood flow in healthy volunteers. Clinical Hemorheology and Microcirculation. 2020. PubMed.

Trofè A, et al. Acute effect of PEMF on muscle oxygenation and its influence on pulmonary oxygen kinetics during exercise. Applied Sciences. 2021;11(8):3624. Full text.

Impact of pulsed electromagnetic field therapy on vascular function and blood pressure in hypertensive individuals. 2020. Full text.

The impact of pulsed electromagnetic field therapy on blood pressure and circulating nitric oxide levels: a double blind, randomized study in subjects with metabolic syndrome. 2019. PubMed.